81245-24-1

Basic information

• Product Name: METHYL 2-METHOXY-4-METHYLBENZOATE
• Synonyms: METHYL 2-METHOXY-4-METHYLBENZOATE;2-Methoxy-4-Methylbenzoic acid Methyl ester;Methyl 4-Methyl-2-Methoxybenzoate;Methyl o-methoxy-p-toluate;Benzoic acid, 2-Methoxy-4-Methyl-, Methyl ester
• CAS NO: 81245-24-1
• Molecular Formula: C₁₀H₁₂O₃
• Molecular Weight: 180.2
• Mol File: 81245-24-1.mol
• Article Data: 41

Chemical Properties

• Melting Point: 29℃
• Boiling Point: 263-265℃
• Flash Point: 106.3°C
• Appearance: /
• Density: 1.075g/cm³
• Vapor Pressure: 0.00835mmHg at 25°C
• Refractive Index: 1.5230 (589.3 nm 18℃)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: METHYL 2-METHOXY-4-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-METHOXY-4-METHYLBENZOATE(81245-24-1)
• EPA Substance Registry System: METHYL 2-METHOXY-4-METHYLBENZOATE(81245-24-1)

Safety Data

• Hazardous Substances Data: 81245-24-1(Hazardous Substances Data)

Usage

General Description

Methyl 2-methoxy-4-methylbenzoate is a chemical compound with the molecular formula C10H12O3. It is a colorless, oily liquid that is commonly used as a fragrance ingredient in cosmetics and personal care products. METHYL 2-METHOXY-4-METHYLBENZOATE is known for its sweet, fruity odor and is often used as a flavoring agent in food and beverages. It is also used in the production of pharmaceuticals, as well as in the manufacturing of paints and coatings. Methyl 2-methoxy-4-methylbenzoate is considered to be relatively stable under normal conditions, but it may undergo hazardous reactions when exposed to heat, flames, or certain chemicals. Therefore, it should be handled and stored with proper caution and safety measures.

InChI:InChI=1/C10H12O3/c1-7-4-5-8(10(11)13-3)9(6-7)12-2/h4-6H,1-3H3

Upstream product

• 67-56-1 methanol 
• 704-45-0 2-methoxy-4-methylbenzoic acid 
• 51671-69-3 2-Methoxy-4-methylbenzoyl chloride 
• 67116-21-6 6-methoxy-4-methyl-2H-pyran-2-one 
• 922-67-8 propynoic acid methyl ester 
• 50-85-1 2-hydroxy-p-toluic acid 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 
• 586-30-1 3-hydroxy-4-methylbenzoic acid 
• 67-64-1 acetone 
• 4670-56-8 methyl 2-hydroxy-4-methylbenzoate 
• 35633-35-3 2-methoxy-4-methylacetophenone 
• 122-46-3 3-acetoxytoluene 
• 6921-64-8 4'-hydroxy-2'-methylacetophenone 

Downstream Products

• 704-45-0 2-methoxy-4-methylbenzoic acid 
• 92242-77-8 6-carbomethoxy-3,6-dimethyl-1-methoxy-1,4-cyclohexadiene 
• 1057652-79-5 methyl 2-methoxy-4-methyl-5-nitrobenzoate 
• 74733-27-0 methyl 4-bromomethyl-2-methoxybenzoate 
• 1351169-42-0 methyl 2-(3-{2-[2-(2-{2-[(S)-2-((2S,3R)-3-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-hydroxy-4-phenylbutanamido)-4-methylpentanamido]ethoxy}ethoxy)ethoxy]acetamido}propoxy)-4-[(E)-3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]benzoate 
• 1351169-27-1 2-[3-(2-{2-[2-(2-{(S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanamido}ethoxy)ethoxy]ethoxy}acetamido)propoxy]-4-[(E)-3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]benzoic acid 
• 1351169-43-1 (S,E)-methyl 4-[3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]-2-(3-{2-[2-(2-{2-[4-methyl-2-(4-phenylbutanamido)pentanamido]ethoxy}ethoxy)ethoxy]acetamido}propoxy)benzoate 
• 1351169-28-2 (S,E)-4-[3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]-2-(3-{2-[2-(2-{2-[4-methyl-2-(4-phenylbutanamido)pentanamido]ethoxy}ethoxy)ethoxy]acetamido}propoxy)benzoic acid 
• 1351169-33-9 C₂₆H₃₂O₄ 
• 1351169-34-0 C₂₅H₃₁BrO₄ 
• 1351169-35-1 (E)-methyl 4-[3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]-2-hydroxybenzoate 
• 1351169-36-2 (E)-methyl 2-[3-(tert-butoxycarbonylamino)propoxy]-4-[3-(3,5-di-tert-butylphenyl)-3-oxoprop-1-enyl]benzoate 
• 1351169-37-3 (E)-methyl 2-(3-aminopropoxy)-4-[3-(3,5-di-tertbutylphenyl)-3-oxoprop-1-enyl]benzoate hydrochloride 
• 57757-74-1 3-Methoxy-4-(methoxycarbonyl)benzyl Alcohol 

Relevant articles and documents

Compounds with neuroprotective effect, and preparation method and application thereof

The invention relates to compounds with a neuroprotective effect, and a preparation method and application thereof. Specifically, the compounds disclosed by the invention have a structure as shown in a formula I, and the definitions of all groups and subs

ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-1" PATHWAY AND METHODS OF USE THEREOF

The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.

ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I" PATHWAY AND METHODS OF USE THEREOF

The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.